HCA Healthcare Statistics
Total Valuation
HCA Healthcare has a market cap or net worth of $114.17 billion. The enterprise value is $159.43 billion.
Important Dates
The last earnings date was Friday, October 24, 2025, before market open.
| Earnings Date | Oct 24, 2025 |
| Ex-Dividend Date | Dec 15, 2025 |
Share Statistics
HCA Healthcare has 228.19 million shares outstanding. The number of shares has decreased by -7.57% in one year.
| Current Share Class | 228.19M |
| Shares Outstanding | 228.19M |
| Shares Change (YoY) | -7.57% |
| Shares Change (QoQ) | -2.37% |
| Owned by Insiders (%) | 1.16% |
| Owned by Institutions (%) | 63.68% |
| Float | 156.42M |
Valuation Ratios
The trailing PE ratio is 19.38 and the forward PE ratio is 17.04. HCA Healthcare's PEG ratio is 1.31.
| PE Ratio | 19.38 |
| Forward PE | 17.04 |
| PS Ratio | 1.63 |
| Forward PS | 1.45 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.10 |
| P/OCF Ratio | 8.89 |
| PEG Ratio | 1.31 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.56, with an EV/FCF ratio of 19.69.
| EV / Earnings | 25.13 |
| EV / Sales | 2.14 |
| EV / EBITDA | 10.56 |
| EV / EBIT | 13.70 |
| EV / FCF | 19.69 |
Financial Position
The company has a current ratio of 0.85
| Current Ratio | 0.85 |
| Quick Ratio | 0.64 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.86 |
| Debt / FCF | 5.72 |
| Interest Coverage | 5.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 12.20% |
| Return on Invested Capital (ROIC) | 16.18% |
| Return on Capital Employed (ROCE) | 27.80% |
| Revenue Per Employee | $235,354 |
| Profits Per Employee | $20,076 |
| Employee Count | 316,000 |
| Asset Turnover | 1.25 |
| Inventory Turnover | 24.84 |
Taxes
In the past 12 months, HCA Healthcare has paid $1.99 billion in taxes.
| Income Tax | 1.99B |
| Effective Tax Rate | 21.39% |
Stock Price Statistics
The stock price has increased by +52.90% in the last 52 weeks. The beta is 1.38, so HCA Healthcare's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | +52.90% |
| 50-Day Moving Average | 453.62 |
| 200-Day Moving Average | 385.45 |
| Relative Strength Index (RSI) | 64.73 |
| Average Volume (20 Days) | 1,310,906 |
Short Selling Information
The latest short interest is 4.54 million, so 1.99% of the outstanding shares have been sold short.
| Short Interest | 4.54M |
| Short Previous Month | 3.26M |
| Short % of Shares Out | 1.99% |
| Short % of Float | 2.90% |
| Short Ratio (days to cover) | 3.24 |
Income Statement
In the last 12 months, HCA Healthcare had revenue of $74.37 billion and earned $6.34 billion in profits. Earnings per share was $25.82.
| Revenue | 74.37B |
| Gross Profit | 30.77B |
| Operating Income | 11.63B |
| Pretax Income | 9.29B |
| Net Income | 6.34B |
| EBITDA | 15.10B |
| EBIT | 11.63B |
| Earnings Per Share (EPS) | $25.82 |
Full Income StatementBalance Sheet
The company has $1.09 billion in cash and $46.35 billion in debt, giving a net cash position of -$45.26 billion or -$198.33 per share.
| Cash & Cash Equivalents | 1.09B |
| Total Debt | 46.35B |
| Net Cash | -45.26B |
| Net Cash Per Share | -$198.33 |
| Equity (Book Value) | -2.16B |
| Book Value Per Share | -23.21 |
| Working Capital | -2.61B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $12.84 billion and capital expenditures -$4.74 billion, giving a free cash flow of $8.10 billion.
| Operating Cash Flow | 12.84B |
| Capital Expenditures | -4.74B |
| Free Cash Flow | 8.10B |
| FCF Per Share | $35.48 |
Full Cash Flow StatementMargins
Gross margin is 41.38%, with operating and profit margins of 15.64% and 8.53%.
| Gross Margin | 41.38% |
| Operating Margin | 15.64% |
| Pretax Margin | 12.50% |
| Profit Margin | 8.53% |
| EBITDA Margin | 20.30% |
| EBIT Margin | 15.64% |
| FCF Margin | 10.89% |
Dividends & Yields
This stock pays an annual dividend of $2.88, which amounts to a dividend yield of 0.57%.
| Dividend Per Share | $2.88 |
| Dividend Yield | 0.57% |
| Dividend Growth (YoY) | 9.09% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 11.15% |
| Buyback Yield | 7.57% |
| Shareholder Yield | 8.14% |
| Earnings Yield | 5.56% |
| FCF Yield | 7.09% |
Dividend DetailsAnalyst Forecast
The average price target for HCA Healthcare is $463.06, which is -7.45% lower than the current price. The consensus rating is "Buy".
| Price Target | $463.06 |
| Price Target Difference | -7.45% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 5.72% |
| EPS Growth Forecast (5Y) | 13.70% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCA Healthcare has an Altman Z-Score of 2.56 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.56 |
| Piotroski F-Score | 6 |
